199 related articles for article (PubMed ID: 10473267)
1. Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor.
Cavalli A; Babey AM; Loh HH
Neuroscience; 1999; 93(3):1025-31. PubMed ID: 10473267
[TBL] [Abstract][Full Text] [Related]
2. Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor.
Tso PH; Yung LY; Wong YH
J Neurochem; 2000 Apr; 74(4):1685-93. PubMed ID: 10737627
[TBL] [Abstract][Full Text] [Related]
3. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.
Niroomand F; Mura RA; Piacentini L; Kübler W
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):643-9. PubMed ID: 8938664
[TBL] [Abstract][Full Text] [Related]
4. Functional role of amino-terminal serine16 and serine27 of G alphaZ in receptor and effector coupling.
Ho MK; Wong YH
J Neurochem; 1997 Jun; 68(6):2514-22. PubMed ID: 9166747
[TBL] [Abstract][Full Text] [Related]
5. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
Chan JS; Chiu TT; Wong YH
J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
[TBL] [Abstract][Full Text] [Related]
6. Effects of C-terminal truncation of the recombinant delta-opioid receptor on phospholipase C and adenylyl cyclase coupling.
Hirst RA; Smart D; Devi LA; Lambert DG
J Neurochem; 1998 Jun; 70(6):2273-8. PubMed ID: 9603191
[TBL] [Abstract][Full Text] [Related]
7. Expression of alpha-transducin in Chinese hamster ovary cells stably transfected with the human delta-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation.
Rubenzik M; Varga E; Stropova D; Roeske WR; Yamamura HI
Mol Pharmacol; 2001 Nov; 60(5):1076-82. PubMed ID: 11641436
[TBL] [Abstract][Full Text] [Related]
8. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
[TBL] [Abstract][Full Text] [Related]
9. Regulation of spontaneous activity of the delta-opioid receptor: studies of inverse agonism in intact cells.
Merkouris M; Mullaney I; Georgoussi Z; Milligan G
J Neurochem; 1997 Nov; 69(5):2115-22. PubMed ID: 9349557
[TBL] [Abstract][Full Text] [Related]
10. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
Law PY; Bergsbaken C
J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
[TBL] [Abstract][Full Text] [Related]
11. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
Carter BD; Medzihradsky F
Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
[TBL] [Abstract][Full Text] [Related]
12. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
Lawrence DM; Bidlack JM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
[TBL] [Abstract][Full Text] [Related]
13. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z
J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909
[TBL] [Abstract][Full Text] [Related]
14. The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site.
Befort K; Tabbara L; Bausch S; Chavkin C; Evans C; Kieffer B
Mol Pharmacol; 1996 Feb; 49(2):216-23. PubMed ID: 8632752
[TBL] [Abstract][Full Text] [Related]
15. Voltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors.
Piros ET; Prather PL; Law PY; Evans CJ; Hales TG
Mol Pharmacol; 1996 Oct; 50(4):947-56. PubMed ID: 8863841
[TBL] [Abstract][Full Text] [Related]
16. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
[TBL] [Abstract][Full Text] [Related]
17. Receptor-induced beta gamma release from fatty acylation-deficient mutants of G alpha z.
Beck HI; Chan JS; Wong YH
Neuroreport; 1997 Mar; 8(4):937-40. PubMed ID: 9141068
[TBL] [Abstract][Full Text] [Related]
18. Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells.
Cruciani RA; Dvorkin B; Morris SA; Crain SM; Makman MH
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3019-23. PubMed ID: 8385355
[TBL] [Abstract][Full Text] [Related]
19. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation.
Chakrabarti S; Yang W; Law PY; Loh HH
Mol Pharmacol; 1997 Jul; 52(1):105-13. PubMed ID: 9224819
[TBL] [Abstract][Full Text] [Related]
20. Transfection of NG108-15 cells with antisense opioid-binding cell adhesion molecule cDNA alters opioid receptor-G-protein interaction.
Govitrapong P; Zhang X; Loh HH; Lee NM
J Biol Chem; 1993 Aug; 268(24):18280-5. PubMed ID: 8394363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
